Zealand Pharma A/S (Denmark)'s ticker is and the CUSIP is 999999999. A total of 2 filers reported holding Zealand Pharma A/S (Denmark) in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,036,683 | -9.2% | 38,171,626 | +34.3% | 4.58% | -1.3% |
Q2 2023 | $34,191,309 | +13.5% | 28,415,026 | -3.7% | 4.64% | +13.9% |
Q1 2023 | $30,112,934 | +148.6% | 29,516,951 | +222.7% | 4.08% | +133.3% |
Q4 2022 | $12,114,379 | +6.1% | 9,147,376 | 0.0% | 1.75% | +0.6% |
Q3 2022 | $11,414,000 | -36.7% | 9,147,376 | +9.1% | 1.74% | -38.9% |
Q2 2022 | $18,028,000 | -25.4% | 8,385,984 | +17.4% | 2.84% | -8.7% |
Q1 2022 | $24,161,000 | -19.0% | 7,144,602 | 0.0% | 3.11% | +3.9% |
Q4 2021 | $29,839,000 | -25.8% | 7,144,602 | +0.7% | 2.99% | -24.2% |
Q3 2021 | $40,233,000 | -15.5% | 7,094,602 | 0.0% | 3.95% | -16.0% |
Q2 2021 | $47,607,000 | +0.2% | 7,094,602 | 0.0% | 4.70% | -11.5% |
Q1 2021 | $47,500,000 | +50.7% | 7,094,602 | 0.0% | 5.31% | +32.5% |
Q4 2020 | $31,523,000 | +10.6% | 7,094,602 | 0.0% | 4.00% | -14.2% |
Q3 2020 | $28,499,000 | +17.6% | 7,094,602 | -0.4% | 4.67% | +9.9% |
Q2 2020 | $24,242,000 | +43.5% | 7,120,843 | -37.0% | 4.25% | -5.2% |
Q1 2020 | $16,896,000 | -25.8% | 11,301,191 | -0.7% | 4.48% | +0.7% |
Q4 2019 | $22,783,000 | +14.3% | 11,383,800 | -7.2% | 4.45% | +5.2% |
Q3 2019 | $19,941,000 | -28.4% | 12,270,185 | -15.0% | 4.23% | -20.5% |
Q2 2019 | $27,836,000 | +19.2% | 14,428,615 | +94.2% | 5.32% | +15.8% |
Q1 2019 | $23,348,000 | +34.6% | 7,428,615 | -22.5% | 4.60% | +21.7% |
Q4 2018 | $17,347,000 | +302.0% | 9,588,606 | +352.6% | 3.78% | +429.5% |
Q3 2018 | $4,315,000 | -10.6% | 2,118,430 | 0.0% | 0.71% | -11.5% |
Q2 2018 | $4,826,000 | -12.8% | 2,118,430 | -92.6% | 0.81% | -24.5% |
Q1 2018 | $5,534,000 | -20.5% | 28,766,223 | +169.3% | 1.07% | -21.0% |
Q4 2017 | $6,964,000 | +998.4% | 10,681,637 | +2058.2% | 1.35% | +1064.7% |
Q3 2016 | $634,000 | -71.8% | 494,939 | -83.5% | 0.12% | -75.4% |
Q1 2016 | $2,250,000 | 0.0% | 3,000,000 | 0.0% | 0.47% | +8.3% |
Q3 2015 | $2,250,000 | -94.6% | 3,000,000 | -97.3% | 0.44% | -92.6% |
Q2 2015 | $41,338,000 | -3.2% | 111,068,490 | -1.5% | 5.87% | -0.6% |
Q1 2015 | $42,694,000 | +11.1% | 112,722,066 | -6.0% | 5.90% | +12.7% |
Q4 2014 | $38,421,000 | – | 119,939,789 | – | 5.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MARXE AUSTIN W & GREENHOUSE DAVID M | 134,268,164 | $56,907,000 | 7.76% |